The medical device industry has shifted from purely mechanical products to technology-driven solutions like robotics, navigation systems, AI, and neuro-monitoring. However, this poses challenges for startups competing with well-funded multinationals. Understanding this, Rivarp Medical rises to this challenge by delivering innovative, accessible surgical technologies to emerging markets with agility and expertise.
Rivarp Medical was founded by seasoned professionals with decades of global experience in medical device design, manufacturing, and distribution. Leading the team from the front is M T Naidu, who is associated with the industry since over 3 decades. Committed to the Government of India’s ‘Make in India’ initiative, the company delivers innovative, high-quality solutions that steer advancements in healthcare, earning trust across India and expanding steadily into global markets.
Core Specializations
Today, Rivarp Medical operates in three key areas, namely cardiology, spinal implants and Neurosciences. In cardiology, the company specializes in pediatric products like ASDs, PDAs, and VSD occluders, along with a full range of cath lab consumables from needles to stents. By collaborating with healthcare professionals and researchers, the company strives to improve cardiac care and patient outcomes globally. It offers high-quality consumables like puncture needles, introducer sheaths, angio wires, and catheters, while developing imaging catheters for early anomaly detection.
Additionally, it is also advancing device-based treatments, including Septal Occluders (ASD, PDA & VSD), coronary balloons, and stents.
"We are proud to be the first in India to manufacture occluders entirely inhouse, setting us apart from others who rely on imported products", states M T Naidu, Chairman, Rivarp Medical. With respect to spine products, it offers a wide portfolio covering degeneration, deformity, fusion, and non-fusion, providing one of the most comprehensive ranges in the market.
Furthermore, the company specializes in spinal implants and lifetime-use consumables for spinal fusion and decompression. It offers MIS implants, retractors, and surgeon training to improve efficiency, reduces costs, and enhances patient outcomes.
Additionally, it also provides highquality consumables that enable faster, accurate diagnoses, helping clinicians reduce procedure time and fluoroscopy exposure for safer interventions. Rivarp Medical has entered the Neurosciences segment, offering advanced solutions like Intraoperative Neuromonitoring (IONM) systems for Neuro, Spine, and ENT surgeries. These technologies enhance surgical safety and reduce postoperative deficits. Rivarp Medical's focus on accessible, high-end innovations marks a key advancement in making safer neurosurgical procedures widely available in India.
Driving Quality Excellence
Quality covers the entire process, right from raw material selection to manufacturing, in-process checks, final QC, and delivery quality. The company has established strict SOPs with multiple QC checkpoints, including componentwise, assembly, and post-assembly inspections using precise gauges like go/no-go gauges. Unlike many in the industry, Rivarp Medical strictly adheres to all regulatory standards, including mechanical, biocompatibility, and CDSCO requirements. This rigorous approach has even enabled the company to achieve US FDA approval for one of its products at an early stage.
Despite limited resources, it ensures thorough training across all levels, building a strong quality-driven culture through consistent training and clear SOPs. The company proudly holds ISO 13485 and ISO 9001 certifications and has applied for CE marking to expand into the European market.
Rivarp Medical ensures quality through rigorous training, strict protocols, and comprehensive testing per CDSCO standards, closely monitored by Regulatory and QA/ RA teams, especially for cardiology and spinal implants. Additionally, customer feedback is systematically collected by the field force, analyzed, and shared with product teams for continuous improvement, supported by a 24/7 customer care team.
Future Roadmap
Rivarp Medical strives to deliver advanced, cost-effective solutions that improve patient outcomes in India with main focus on unique products, IONM devices, Neurovascular coils and future robotics. The company targets ₹100 crore revenue, with future plans for IPO, international expansion, and new cardiology innovations.
We use cookies to ensure you get the best experience on our website. Read more...